Takeda Pharmaceutical TAK
NYSE TAK
$18.16 -0.18 (-0.98%)
At close: Aug 20, 2026 · 2:05 PM UTC

Takeda Pharmaceutical (TAK) Revenue (QoQ) (2018 - 2026)

Takeda Pharmaceutical (TAK) Revenue (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.61%
Mar 31, 2026 9.38%
Dec 31, 2025 -70.30%
Sep 30, 2025 213.07%
Jun 30, 2025 -3.40%
Mar 31, 2025 14.27%
Dec 31, 2024 -70.71%
Sep 30, 2024 204.81%
Jun 30, 2024 -4.80%
Mar 31, 2024 14.65%
Dec 31, 2023 -68.04%
Sep 30, 2023 188.01%
Jun 30, 2023 -3.48%
Mar 31, 2023 3.11%
Dec 31, 2022 6.95%
Sep 30, 2022 -3.49%
Jun 30, 2022 -10.14%
Mar 31, 2022 5.54%
Dec 31, 2021 3.32%
Sep 30, 2021 -11.53%